Long-term cost effectiveness of addiction treatment for criminal offenders

Justice Quarterly

Volumn 21, Issue 3, 2004, Pages 659-679

  McCollister, Kathryn E ^a,d   French, Michael T ^a,e,f   Prendergast, Michael L ^b,g   Hall, Elizabeth ^b,g   Sacks, Stan ^c,h  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Department of Biology   (United States)

^f University of Miami ^*

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Center for the Integration fo Research and Practice

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28344457815     PISSN: 07418825     EISSN: 17459109     Source Type: Journal    
DOI: 10.1080/07418820400095941     Document Type: Review

References (56)

1. American Medical Association. (1999). Medicare physician fee schedule. Chicago: Author.
2. Aos, S., Phipps, P., Barnoski, R., & Lieb, R. (2001). The comparative costs and benefits of programs to reduce crime: A review of national research findings with implications for Washington State. Olympia, WA: Washington State Institute for Public Policy.
3. Benson, B. L., Kim, I., Rassmussen, D. W., & Zuehlke, T. W. (1992). Is property crime caused by drug use or by drug enforcement policy? Applied Economics, 24, 679-692.
4. Bureau of Justice Statistics. (2002). Justice expenditure and employment in the U.S. 1999. NCJ 191746. [Online]. Available: http://www.ojp.usdoj.gov/bjs/
5. Bureau of Justice Statistics. (2003). Prison and jail inmates at midyear 2002. (BJS Bulletin NCJ 198877 by P. M. Harrison & J. C. Karberg). [Online]. Available: http://www.ojp.usdoj.gov/bjs/
6. California Department of Alcohol and Drug Programs. Proposed drug Medi-Cal rates for fiscal year 2000-2001. [Online]. Available: http://www.adp.ca.gov
7. California State Auditor. (1998). California Department of Corrections: The cost of incarcerating inmates in state-run prisons is higher than the department's published cost. Sacramento, CA: Bureau of State Audits.
8. Chaiken, J. M., & Chaiken, M. R. (1990). Drugs and predatory crime. In M. Tonry & J. Q. Wilson (Eds.) Drugs and crime (pp. 203-239). Chicago: University of Chicago Press.
9. Drummond, M. F., O'Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health care programmes (2nd ed.). Oxford: Oxford University Press.
10. Field, G. D. (2002). Historical trends of drug treatment in the criminal justice system. In C. G. Leukefeld, F. Tims, & D. Farabee (Eds.), Treatment of Drug Offenders: Policies and Issues (pp. 9-21). New York: Springer Publishing Company.
11. French, M. T. (2000). Economic evaluation of alcohol treatment services. Evaluation and Program Planning, 23, 27-39.
12. French, M. T. (2002a). Drug abuse treatment cost analysis program (datcap): program version user's manual (7th ed.) Miami, FL: University of Miami.
13. French, M. T. (2002b). Drug abuse treatment cost analysis program (DATCAP): Program Version (7th ed.) Miami, PL: University of Miami.
14. French, M. T., McCollister, K. E., Sacks, S. McKendrick, K. & De Leon, G. (2002). Benefit-cost analysis of a modified therapeutic community for mentally ill chemical abusers. Evaluation and Program Planning, 21, 137-148.
15. French, M. T., McGeary, K. A., Chitwood, D. D., McCoy, C. B., Inciardi, J. A., & McBride, D. (2000). Chronic drug use and crime. Substance Abuse, 21, 95-109.
16. Gerstein, D. R. & Johnson, R. A. (2001). Nonresponse and selection bias in treatment follow-up studies. Substance Use and Misuse, 36, 1749-51, 1753-7.
17. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. Oxford: Oxford University Press.
18. Graham, W. F. & Wexler, H. K. (1997). The Amity Therapeutic Community program at Donovan prison: Program description and approach. In G. De Leon (Ed.), Community as method: Therapeutic communities for special populations and settings (pp. 69-86). New York: Praeger.
19. Griffith, J. D., Killer, M. L., Knight, K., & Simpson, D. D. (1999). A cost-effectiveness analysis of in-prison therapeutic community treatment and risk classification. The Prison Journal, 79, 352-368.
20. Miller, M. L., Knight, K., & Simpson, D. D. (1999). Prison-based substance abuse treatment, residential aftercare and recidivism. Addiction, 94, 833-842.
21. Hudson, D., Seah, L., Hite, D., & Haab, T. (2004). Telephone presurveys, self-selection, and non-response bias to mail and internet surveys in economic research. Applied Economics Letters, 11, 237-240.
22. Humphreys, K., & Moos, R. (1996). Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services, 47, 709-713.
23. Inciardi, J. A. (1979). Heroin and street crime. Crime & Delinquency, 25, 333-346.
24. Inciardi, J. A., & Pottieger, A. E. (1994). Crack-cocaine use and street crime. Journal of Drug Issues, 24, 273-292
25. Inciardi, J., Martin, S. S., Butzin, C. A., Hooper, R. M., & Harrison, L. D. (1997). An effective model of prison-based treatment for drug-involved offenders. Journal of Drug Issues, 27, 261-278.
26. John, U., Rumpf, H. J., & Hapke, U. (1999). Estimating prevalence of alcohol abuse and dependence in one general hospital: An approach to reduce sample selection bias. Alcohol and Alcoholism, 34, 786-794.
27. Kenkel, D. (1997). On valuing morbidity, cost-effectiveness analysis, and being rude. Journal of Health Economics, 16, 749-757.
28. Knight, K., Simpson, D. D., & Killer, M. L. (1999). Three-year reincarceration outcomes for in-prison therapeutic community treatment in Texas. The Prison Journal, 79, 337-351.
29. Leukefeld, C. G. (1985). The clinical connection: Drugs and Crime. International Journal of the Addictions, 20, 1049-1064.
30. Lipton, D. S. (1995). The effectiveness of treatment for drug abusers under criminal justice supervision. Presentation at the 1995 Conference on Criminal Justice Research and Evaluation.
31. Logan, T., Hoyt, W., McCollister, K., French, M., Leukefeld, C., & Minton, L. (in press). Economic evaluation of Drug Court: Methodology, results, and policy implications. Evaluation and Program Planning.
32. Lowe, L., Wexler, H. K., & Peters, J., (1998). The R.J. Donovan in-prison and community substance abuse program: Three-year return-to-custody data. Sacramento, CA: Office of Substance Abuse Programs, California Department of Corrections.
33. Martin, S. S., Butzin, C. A., Saum, C. A., & Inciardi, J. A. (1999). Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: From prison to work release to aftercare. The Prison Journal, 79, 294-320.
34. Martinson, R. (1974), What works? Questions and answers about prison reform. Public Interest, 35, 22-54.
35. Mauser, E., Van Stelle, K. R., & Moberg, D. P. (1994). The economic impact of diverting substance abusing offenders into treatment, Crime & Delinquency, 40, 568-588.
36. McCollister, K. E., & French, M. T. (2002). The cost of drug abuse treatment in criminal justice settings. In C. Leukefeld, F. Tims, & D. Farabee (Eds.), Treatment of drug offenders: Policies and issues (pp. 22-37). New York: Springer.
37. McCollister, K. E., French, M. T., Inciardi, J. A., Butzin, C. A., Martin, S. S., & Hooper, R. M. (2003). A cost-effectiveness analysis of post-release substance abuse treatment for criminal offenders. Journal of Quantitative Criminology, 19, 389-407.
38. McCollister, K. E., French, M. T., Prendergast, M., Wexler, H., Sacks, S., & Hall, E. (2003). Is in-prison treatment enough? A cost-effectiveness analysis of prison-based treatment and aftercare services for substance abusing offenders. Law and Policy, 25, 62-83.
39. Mears, D. P., Winterfield, L., Hunsaker, J., Moore, G. E., & White, R. M. (2003). Drug treatment in the criminal justice system: The current state of knowledge. Washington, DC: Urban Institute, Justice Policy Center.
40. Morimoto, L. M., White, E., & Newcomb, P.A. (2003). Selection bias in the assessment of gene-environment interaction in case-control studies. American Journal of Epidemiology, 158, 259-263.
41. Mullen, R., Rowland, J. Abraham, E., & Boyle, J. (1996). California's first prison therapeutic community: A 10-year report. Offender Substance Abuse Report, 1, 17-18, 26-30.
42. Myers, D. L. (2003). The recidivism of violent youths in juvenile and adult court: A consideration of selection bias. Youth Violence and Juvenile Justice, 1, 79-101.
43. Nurco, D. N., Hanlon, T. E., & Kinlock, T. W. (1991). Recent research on the relationship between illicit drug use and crime. Behavioral Sciences and the Law, 9, 221-242.
44. Nurco, D. N., Hanlon, T. E., Kinlock, T. W., & Duszynski, K. R. (1988). Differential criminal patterns of narcotic addicts over an addiction career. Criminology, 25, 407-423.
45. Office of National Drug Control Policy. (2001) Drug treatment in the criminal justice system. ONDCP Drug Policy Information Clearinghouse Fact Sheet. Washington, DC: Author.
46. Porpino, F. J., Robinson, D., Millson, B., & Weekes, J. R. (2002). An outcome evaluation of prison-based treatment programming for substance users. Substance Use & Misuse, 37, 1047-1077.
47. Prendergast, M. L., & Wexler, H. K. (2004). Correctional substance abuse treatment programs in California: A historical perspective. The Prison Journal, 84, 1-28.
48. Prendergast, M. L., Hall, E. H., Wexler, H. K., Melnick, G. & Cao, Y. (2004). Amity prison-based Therapeutic Community: Five-year outcomes. The Prison Journal 84, 36-60.
49. Rhodes, W., Pelissier, B., Gaes, G., Saylor, W., Camp, S., & Wallace, S. (2001). Alternative solutions to the problem of selection bias in an analysis of federal residential drug treatment programs. Evaluation Review, 25, 331-369.
50. Roebuck, M. C., French, M. T., & McLellan, A. T. (2003). DATStats: Summary Results from 85 Completed Drug Abuse Treatment Cost Analysis Programs (DATCAPs). Journal of Substance Abuse Treatment, 25, 51-57.
51. Speckart, G., & Anglin, M. D. (1986). Narcotics and crime: An overview of recent research advances. Contemporary Drug Problems, 13, 741-769.
52. StataCorp. (1999). Stata statistical software: Release 8. College Station, TX: Author.
53. U.S. Department of Justice, National Institute of Justice. (2001). Arrestee drug abuse monitoring (ADAM) preliminary 2000 findings on drug use and drug markets. Research Report. Rockville, MD: National Criminal Justice Reference Services.
54. We Care Medical Mall (WCMM). [Online.] Available: http://www.a2zmedline. com/substance_abuse.htm
55. Wexler, H. K., De Leon, G., Thomas, G., Kressel, D., & Peters, J. (1999). The Amity prison TC evaluation: Reincarceration outcomes. Criminal Justice and Behavior, 26, 147-167.
56. Wexler, H. K., Melnick, G., Lowe, L., & Peters, J. (1999). Three-year reincarceration outcomes for Amity in-prison therapeutic community and aftercare in Delaware. The Prison Journal, 79, 321-336.